260
Views
62
CrossRef citations to date
0
Altmetric
Articles

Adiponectin mitigates the severity of arthritis in mice with collagen‐induced arthritis

, , , &
Pages 260-268 | Accepted 11 Jan 2008, Published online: 12 Jul 2009
 

Abstract

Objective: Adiponectin (AD) is considered an inflammation modulator. In this study, we investigated the effect of AD on rheumatoid arthritis (RA) using a collagen‐induced arthritis (CIA) mouse model and RA synovial fibroblasts (RASF).

Methods: Fifteen DBA/1 mice were divided into three groups. All mice, except the control group, were injected with type II collagen. AD was intra‐articularly injected in the left hind legs after arthritis development (the AD‐treated group). The severity of the arthritis was measured using an arthritis score and paw thickness. A histopathological assessment of joint sections was performed by haematoxylin/eosin (H&E) staining. Tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β, IL‐6, and matrix metalloproteinase (MMP)‐3 expression was evaluated by immunohistochemical staining in the CIA mice. Synovial tissue was obtained from four RA patients during total joint replacement. RASF cultures were established from this tissue. RASF were pretreated with AD and stimulated by TNFα or IL‐1β. TNFα, IL‐1β, IL‐6, and MMP‐3 production was measured by enzyme‐linked immunosorbent assay (ELISA) and reverse transcription polymerase chain reaction (RT‐PCR). RASF proliferation was evaluated using the MTT assay.

Results: AD significantly mitigated the severity of the arthritis and histopathological findings indicative of RA in CIA mice. TNFα, IL‐1β, and MMP‐3 expression decreased, but IL‐6 expression in AD‐treated joint tissues increased. Moreover, AD reduced TNFα, IL‐1β, and MMP‐3 expression in stimulated RASF and increased IL‐6 expression in IL‐1β‐stimulated RASF. AD significantly inhibited IL‐1β‐induced RASF proliferation, despite increased IL‐6 expression.

Conclusion: These data suggest that AD may play an anti‐inflammatory role in the pathophysiology of RA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.